Cargando…
Oncolytic adenovirus programmed by synthetic gene circuit for cancer immunotherapy
Improving efficacy of oncolytic virotherapy remains challenging due to difficulty increasing specificity and immune responses against cancer and limited understanding of its population dynamics. Here, we construct programmable and modular synthetic gene circuits to control adenoviral replication and...
Autores principales: | Huang, Huiya, Liu, Yiqi, Liao, Weixi, Cao, Yubing, Liu, Qiang, Guo, Yakun, Lu, Yinying, Xie, Zhen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6805884/ https://www.ncbi.nlm.nih.gov/pubmed/31641136 http://dx.doi.org/10.1038/s41467-019-12794-2 |
Ejemplares similares
-
Oncolytic Adenovirus in Cancer Immunotherapy
por: Peter, Malin, et al.
Publicado: (2020) -
Oncolytic Adenovirus: Prospects for Cancer Immunotherapy
por: Zhao, Yaqi, et al.
Publicado: (2021) -
Oncolytic virus immunotherapies in ovarian cancer: moving beyond adenoviruses
por: Hoare, Joseph, et al.
Publicado: (2018) -
Safety and Efficacy of an Oncolytic Adenovirus as an Immunotherapy for Canine Cancer Patients
por: Martín-Carrasco, Clara, et al.
Publicado: (2022) -
Synthetic riboswitches for external regulation of genes transferred by replication-deficient and oncolytic adenoviruses
por: Ketzer, Patrick, et al.
Publicado: (2012)